Geode Capital Management’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30K | Hold |
15,870
| – | – | ﹤0.01% | 4306 |
|
|
2025
Q1 | $14.6K | Hold |
15,870
| – | – | ﹤0.01% | 4404 |
|
|
2024
Q4 | $19K | Buy |
15,870
+3,907
| +33% | +$4.69K | ﹤0.01% | 4391 |
|
|
2024
Q3 | $15.2K | Hold |
11,963
| – | – | ﹤0.01% | 4426 |
|
|
2024
Q2 | $13.4K | Hold |
11,963
| – | – | ﹤0.01% | 4516 |
|
|
2024
Q1 | $21.8K | Hold |
11,963
| – | – | ﹤0.01% | 4473 |
|
|
2023
Q4 | $9.39K | Buy |
+11,963
| New | +$9.39K | ﹤0.01% | 4596 |
|